Precision NanoSystems Inc.

Vancouver,  BC 
Canada
http://www.precisionnanosystems.com


Create Transformative Medicines. Translate Biology Insights.

Join us for our presentation: 

  • Accelerating Genetic Medicine Development with Lipid Nanoparticles (LNPs) 
    • May 13th - 2:00 PM - 3:30 PM  - Industry Sponsored Symposia 

Stop by our booth #458 to live chat with one of our scientific specialists, schedule one on one meetings, download our resources, and watch our videos. 

PNI is a global leader ushering in the next wave of genetic medicines in infectious diseases, cancer, and rare diseases. We work with the world's leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine. PNI offers proprietary technology platforms and comprehensive expertise to enable researchers to translate biology insights into non-viral genetic medicines. 


 Products

  • The NanoAssemblr® Ignite™
    Advance Novel Genetic Medicine Formulations

    Genetic medicines have a wide design space that requires optimization to select a lead candidate. The Ignite is ideal for fine-tuning process parameters and compositions for further scale up to the clinic....

  • As part of the NanoAssemblr® Platform, the NanoAssemblr® Ignite™ enables the rapid and controlled manufacture of nanomedicines. Conceived for the development of transformative medicines at the bench scale, the Ignite system has been:

    Designed with the End in Mind

    Develop a robust, scalable process from the earliest stage  A drug product is produced by adhering to the unit process steps necessary for clinical manufacturing. Ignite simplifies the transition into clinical programs by incorporating these fundamental process steps for scale up in the earliest stages of pre-clinical by modelling clinical manufacturing processes at small volumes, costs are reduced, scale up is derisked, and timelines are accelerated.


    Designed for the Future

    Let technology keep pace with your ideas The next generation of gene therapies, vaccines, and targeted medicines are now achievable with the automated, multi-step synthesis made possible with Ignite. NxGen microfluidic technology, together with Ignite’s three-pump format, provide the basis for expansion to enable new, more sophisticated manufacturing capabilities. 


    Designed to Maximize Time

    Manufacturing processes should not be long or complex. Ignite lowers the barrier to developing transformative medicines by providing a simple, precise, and fast platform, allowing you to focus on what matters—bringing solutions to patients.

    Download our brochure here. 



     

  • The NanoAssemblr® Spark™
    The NanoAssemblr Spark enables the acceleration of nanomedicine development through the
    rapid and easy production of ultra-low nanoparticle volumes for discovery....

  • Explore innovative nanomedicine formulations and create revolutionary medicines with the Spark’s scalable and robust microfluidic system, with minimal consumption of starting materials. The Spark system is designed to be seamlessly integrated with in vitro screening workflows: create on-demand formulations in a sterile biosafety hood and apply them directly to cells in culture. The Spark instrument streamlines the screening of various formulation parameters for novel excipients and nanoparticle cargoes. It may also be used in conjunction with PNI’s line of Spark Transfection Kits to formulate particles for in vitro nucleic acid delivery.

    Explore Novel Genetic Medicine Formulations

    Transformative medicines start with novel materials that can be costly or in limited supply. The Spark is ideal for screening novel genetic medicine formulations because it provides:

    Unmatched Sample Recovery

    Advanced microfluidics allows microliter formulation volumes with near-complete sample recovery. 

    Intuitive Operation

    Simply pipette starting materials into wells, push a button and pipetter completed formulations out. 

    Rapid Production

    The Spark formulation process requires less than 10 seconds allowing hundres of formulations to be made in hours. 

    Robust Process

    Electronic control minimizes batch-to-batch and user variability. 

    Workflow Integration

    The Spark system is designed for operation in a sterile biosafety hood, so formulations can be made on-demand, and applied to cells in culture. 

    Scalable

    NxGen microfluidic mixing technology allows formulations to be scaled across the NanoAssemblr Platform to accelerate future development. 

  • The NanoAssemblr® Blaze™
    Power to Scale....

  • The NanoAssemblr® Blaze allows rapid scaling of nanoparticle formulations for late pre-clinical development. The system can manufacture between 10 mL and 10 L of formulation which allows researchers to use the Blaze for preclinical toxicology testing, and for early Chemistry, Manufacturing and Controls (CMC) studies. 

    Download our brochure here.